Article Text

Download PDFPDF
Distribution of hepatitis B viral genotypes and mutations in the core promoter and precore regions in acute forms of liver disease in patients from Chiba, Japan
  1. T Imamura,
  2. O Yokosuka,
  3. T Kurihara,
  4. T Kanda,
  5. K Fukai,
  6. F Imazeki,
  7. H Saisho
  1. Department of Medicine and Clinical Oncology, Graduate School of Medicine, Chiba University, Japan
  1. Correspondence to:
    Dr O Yokosuka
    Department of Medicine and Clinical Oncology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, Japan; yokosukamed.m.chiba-u.ac.jp

Abstract

Background: Although it has been reported that different hepatitis B virus (HBV) genotypes induce different clinical characteristics in patients with chronic liver diseases (CLD), there have been few reports that have detailed the distribution of HBV genotypes in acute forms of liver disease.

Methods: HBV genotypes were determined in 61 patients who had acute forms of liver disease (45 had acute self limited hepatitis (AH) and 16 had fulminant hepatitis (FH)) and in 531 patients with CLD, including 19 patients with severe acute exacerbation of CLD. We also analysed the enhancer II, core promoter, and precore region sequences for the presence of mutations.

Results: Expression of genotype B in patients with acute forms of liver disease was significantly greater than in those with CLD (39.3% v 11.7%, respectively; p<0.001). Furthermore, expression of genotype B was significantly greater in patients with FH than in those with AH (62.5% v 31.1%, respectively; p=0.027). The precore mutation A1896 and the core promoter mutation at nt 1753 and 1754 were found more frequently in FH than in AH, and genotype B was predominant in FH regardless of the presence of these mutations.

Conclusions: HBV genotype B was found more frequently in patients with acute forms of liver disease than in patients with CLD, and more frequently in patients with FH than in those with AH. These results suggest that this HBV genotype may induce more severe liver damage than other viral genotypes, at least in patients from Chiba, Japan.

  • acute self limited hepatitis
  • fulminant hepatitis
  • hepatitis B virus
  • genotype
  • AH, acute self limited hepatitis
  • ALT, alanine aminotransferase
  • CLD, chronic liver diseases
  • ELISA, enzyme linked immunosorbant assay
  • FH, fulminant hepatitis
  • HBV, hepatitis B virus
  • HBeAg, hepatitis B e antigen
  • HBsAg, hepatitis B surface antigen
  • anti-HCV, hepatitis C virus antibody
  • anti-HDV, hepatitis D virus antibody
  • PCR, polymerase chain reaction
  • A1896, G to A mutation at nt 1896 in the precore region
  • T1762 and A1764, A to T mutation at nt 1762 and G to A mutation at nt 1764 in the core promoter region
  • C/A/G 1753 and/or C/G1754, C/A/G to T mutation at nt 1753 and/or C/G to T mutation at nt 1754 in the core promoter region

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes